The Risk Nobody Puts on the List
Why starting the regulatory conversation early is the smartest decision a health tech founder can make.
Health tech founders think about risk constantly. Market risk, technical risk, funding risk. There is one that almost never makes the list. And it is the one most likely to stop you.
It builds quietly. A vague product description. Pilots run without regulatory structure. A quality system nobody actually uses. None of it feels like a crisis at the time. Together, it becomes a problem that cannot be solved with money or momentum.
A quick explanation of what we are talking about
In Europe, any product that qualifies as a medical device must be certified before it can be sold. The law governing this is called the Medical Device Regulation (MDR). It sorts devices into risk classes, from low (Class I) to high (Class III), and that class determines everything: evidence required, timeline, and cost. Selling legally requires a CE mark, granted by an independent certification body called a Notified Body.
The three risks that will not wait:
Misclassification. MDR classifies your device based on what it actually does, not what your disclaimer says. Founders who write vague product descriptions almost always land in a higher class than expected. Correcting it late is expensive. Correcting it after building your entire regulatory strategy around the wrong class can end the company.
The Notified Body queue. Certification bodies are running queues of up to six months just to book a review slot. Founders who discover this at Series A watch their launch slide by a year and their financial model fall apart.
The blocked round. Investors now ask specific questions: device class, Notified Body status, certification timeline. A founder who cannot answer clearly is a founder whose round moves slowly, or not at all.
What starting early actually means
Three things, done before anything is locked in.
- Get your classification right before you write code. It shapes your quality system, your evidence, your timeline, and your budget.
- Write your intended purpose carefully. One paragraph: who uses it, what it does, what decision it supports. Everything in MDR flows from this. Write it loosely and you will rewrite it later at much greater cost.
- Start the Notified Body conversation early. Not the formal submission, just the conversation. Getting into the queue before you are ready to submit is what separates founders who arrive at Series A with a real timeline from those who do not.
Twenty minutes, before it gets expensive
The gap between teams that navigate MDR well and those that do not is almost never talent. It is one honest conversation, before the decisions that are hard to undo have been made.
The free 20-minute assessment at health tech pathways tells you whether MDR applies to your product. Before the architecture is locked. Before the pilots run. Before an investor asks.
Take the free 20-minute MDR assessment at https://healthtechpathways.org/